Convertable Note - Ashvattha Therapeutics - May 31, 2020 Funding Round Profile - Cointime

Bitcoin $79,833.73 +4.89%
Ethereum $3,217.24 +6.25%
BNB $641.05 +3.46%
Optimism $1.72 +7.44%
Arbitrum $0.64 +8.33%
Solana $211.25 +7.34%
Polygon $0.41 +9.52%
Cosmos $5.39 +15.05%
Avalanche $32.67 +13.37%

Bitcoin $79,833.73 +4.89%
Ethereum $3,217.24 +6.25%
BNB $641.05 +3.46%
Optimism $1.72 +7.44%
Arbitrum $0.64 +8.33%
Solana $211.25 +7.34%
Polygon $0.41 +9.52%
Cosmos $5.39 +15.05%
Avalanche $32.67 +13.37%

Ashvattha Therapeutics

company

Funding Round

Convertable Note

Money Raised

$ 22M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Natural Capital	-	Yes	-	Detail
Zephyr Venture Partners	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Mar 15, 2019	Series A	$ 7M	Natural Capital	Detail